SUMO2 pseudogene 3 (SUMO2P3)

SUMO2 pseudogene 3 (SUMO2P3) is a non-coding genomic sequence derived from the SUMO2 gene, belonging to the family of small ubiquitin-like modifier (SUMO) pseudogenes found in the human genome[3][5]. While SUMO2 is an active protein involved in post-translational modification and regulation of transcription, nuclear transport, and stress responses, the SUMO2P3 pseudogene does not express a functional protein and is not implicated in therapeutic intervention or disease mechanisms[3][5]. Pseudogenes may sometimes be transcribed but lack the biological activity of their parent gene. SUMO2P3 is not classified as an enzyme, receptor, transporter, or any active biomolecule and is not a target for known drugs. Furthermore, its presence reflects evolutionary genetic duplication events, but there is no substantial evidence linking SUMO2P3 to clinical biomarkers, drug safety concerns, or noted disease associations[3][5]. In summary, SUMO2P3 is a **pseudogene**, **not a protein-coding gene**, and **not a therapeutic target**. It should not be confused with **SUMO2**, which plays significant biological roles in post-translational modification pathways[3][5].

Other names

SUMO2P3SUMO2-psi3